Haleon plc (HLN)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:46PM EDT. Market open.
| Previous close | 8.40 |
| Open | 8.38 |
| Bid | 8.45 x 29200 |
| Ask | 8.46 x 800 |
| Day's range | 8.38 - 8.47 |
| 52-week range | 7.70 - 8.98 |
| Volume | |
| Avg. volume | 5,702,819 |
| Market cap | 38.589B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 30.18 |
| EPS (TTM) | 0.28 |
| Earnings date | N/A |
| Forward dividend & yield | 0.21 (2.53%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | 9.62 |
Simply Wall St.Haleon plc (LON:HLN) Shares Could Be 24% Above Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...
ZacksPharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
ZacksGSK Outperforms Industry on Strength in Key Drugs & Vaccines
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
© 2024 Yahoo. All rights reserved.